Platelet phenotyping by immunofluorescence microscopy on the blood smear in subjects with myeloprolipherative disorders
Recruiting
- Conditions
- D50-D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Registration Number
- DRKS00032588
- Lead Sponsor
- Klinik für Innere Medizin C, Universitätsmedizin Greifswald
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Ensured diagnosis of clonal, myeloid disorder (CHIP, CCUS, ICUS, MDS, MPN, MDS-MPN-Overlap, CML or MDS/AML according to WHO), as well as healthy controls.
Exclusion Criteria
None.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify possible correlations between platelet phenotype determined by light- and immunofluorescence microscopy and clinical or genetic characteristics of MPN patients that may be diagnostically and prognostically relevant.
- Secondary Outcome Measures
Name Time Method To distinguish MPN patients from healthy controls, based on the found correlations described in the primary endpoint.